Circulating tumor cells and circulating cancer stem cells and their detection by the method of flow cytometry

T. Pozniak, A. Hancharou, V. Abashkin, A. I. Stanovaya, A. Prokhorov, Dzmitry G. Shcharbin
{"title":"Circulating tumor cells and circulating cancer stem cells and their detection by the method of flow cytometry","authors":"T. Pozniak, A. Hancharou, V. Abashkin, A. I. Stanovaya, A. Prokhorov, Dzmitry G. Shcharbin","doi":"10.29235/1029-8940-2021-66-3-370-384","DOIUrl":null,"url":null,"abstract":"This review describes the circulating cancer stem cells (CCSCs) and circulating tumor cells (CTCs). CCSCs are one of the main initiators of recurrent cancer and thus make them an important target for the development of new treatment methods. CTCs are relatively new biomarkers for the early diagnosis of metastasis. CTCs provide doctors with valuable information about each stages of cancer treatments: diagnostic of early-stage disease, early detection of recurrent cancer, the efficiency of chemotherapy, and makes it possible to select an individual sensitive drug.The most informative and frequently used markers for the detection of CSCs and CSCs were described. The mechanism of two models of tumor formation is considered: clonal and hierarchical. The known mechanisms of epithelial-mesenchymal transition of tumor cells are described. The most widely used specific cell surface markers for the detection and isolation of CTCs and CCSCs are described. The efficiency of a sensitive high-precision method of multicolor flow cytometry using specific fluorescent dye-labeled monoclonal antibodies for the detection of CCSCs and CTCs in the blood of cancer patients is analyzed. Detection of CTCs and CCSCs provides important information for the early diagnosis of metastasis and open a possibility to personalized treatment, and to monitoring of all stages cancers.","PeriodicalId":20656,"journal":{"name":"Proceedings of the National Academy of Sciences of Belarus, Biological Series","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the National Academy of Sciences of Belarus, Biological Series","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29235/1029-8940-2021-66-3-370-384","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This review describes the circulating cancer stem cells (CCSCs) and circulating tumor cells (CTCs). CCSCs are one of the main initiators of recurrent cancer and thus make them an important target for the development of new treatment methods. CTCs are relatively new biomarkers for the early diagnosis of metastasis. CTCs provide doctors with valuable information about each stages of cancer treatments: diagnostic of early-stage disease, early detection of recurrent cancer, the efficiency of chemotherapy, and makes it possible to select an individual sensitive drug.The most informative and frequently used markers for the detection of CSCs and CSCs were described. The mechanism of two models of tumor formation is considered: clonal and hierarchical. The known mechanisms of epithelial-mesenchymal transition of tumor cells are described. The most widely used specific cell surface markers for the detection and isolation of CTCs and CCSCs are described. The efficiency of a sensitive high-precision method of multicolor flow cytometry using specific fluorescent dye-labeled monoclonal antibodies for the detection of CCSCs and CTCs in the blood of cancer patients is analyzed. Detection of CTCs and CCSCs provides important information for the early diagnosis of metastasis and open a possibility to personalized treatment, and to monitoring of all stages cancers.
循环肿瘤细胞和循环肿瘤干细胞及其流式细胞术检测
本文综述了循环肿瘤干细胞(CCSCs)和循环肿瘤细胞(ctc)。CCSCs是癌症复发的主要启动物之一,因此成为开发新治疗方法的重要靶点。ctc是早期诊断转移的较新的生物标志物。CTCs为医生提供了有关癌症治疗各个阶段的宝贵信息:早期疾病的诊断、癌症复发的早期发现、化疗的效率,并使选择个别敏感药物成为可能。描述了用于检测CSCs和CSCs的最具信息量和最常用的标记物。考虑了两种肿瘤形成模式的机制:克隆和分级。描述了肿瘤细胞上皮-间质转化的已知机制。描述了用于检测和分离ctc和CCSCs的最广泛使用的特定细胞表面标记物。分析了一种使用特异性荧光染料标记单克隆抗体检测癌症患者血液中CCSCs和ctc的灵敏、高精度多色流式细胞术方法的效率。ctc和CCSCs的检测为早期诊断转移提供了重要信息,并为个性化治疗和监测所有阶段的癌症提供了可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信